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Abstract
Background: Not much is known about the risk factors of major depressive disorder (MDD) in HIV/AIDS in the
African socio-cultural context. Therefore a study was undertaken to examine the prevalence and risk factors of
MDD in HIV/AIDS in semi-urban Uganda.
Methods: A cross-sectional study was undertaken among 618 respondents attending two HIV clinics in Uganda.
Results: Prevalence of MDD was 8.1%. Factors associated with MDD at univariate analysis only were female
gender, family history of mental illness, negative coping style, alcohol dependency disorder, food insecurity and
stress; not associated with MDD were social support, neurocognitive impairment, CD4 counts and BMI. Factors
independently associated with MDD were psychosocial impairment, adverse life events, post traumatic stress
disorder, generalised anxiety disorder and life-time attempted suicide.
Conclusion: Psychological and social factors were the main risk factors of MDD among ambulatory HIV positive
persons with no evidence for the role of the neurotoxic effects of HIV. Treatment approaches for MDD in this
patient group should be modeled on those used among non-HIV groups.
Background
The increasing access to highly effective antiretroviral
therapy (ART) for people living with HIV (PLWHA)
even in low income countries including in sub-Saharan
Africa has delayed HIV disease progression and pro-
longed survival bringing into sharp focus issues of qual-
ity of life including their mental wellbeing [1,2]. One of
the major causes of psychiatric morbidity in HIV/AIDS
is major depressive disorder (MDD), with studies from
Africa reporting point prevalence rates of MDD of
between 3% to 54% [3-8].
Most of these studies however were small, used non-
locally validated screening scales to diagnose MDD and
rarely examined risk factors.
Studies in the west have pointed to a multifactorial
aetiology of MDD in HIV/AIDS including psychological,
social and biological factors [9,10]. How much of these
factors operate in the African socio-cultural environ-
ment is not fully known. The few studies that have been
undertaken in sub-Saharan African point to the follow-
ing risk factors for MDD in HIV/AIDS female gender,
older age, unemployment, negative life events, childhood
trauma, impaired function, poor social support, poor
quality of life and low CD4 counts [5,6,11-13].
This paper examines the prevalence and risk factors of
MDD in HIV/AIDS as seen in the African socio-cultural
context of Uganda with a view to inform the develop-
ment of mental health interventions for PLWHA on the
African sub-continent.
Methods
Study design
This study was undertaken at two HIV clinics in the
semi-urban district of Entebbe, Uganda. This study had
two components a cross section study (from which this
paper is derived) and a longitudinal follow-up compo-
nent (still ongoing). In the cross sectional component of
this study all consenting eligible HIV-infected patients
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attending two HIV clinics in the government health
facilities of Entebbe District Hospital and Kigungu
Health Centre III were continuously enrolled into this
study. Eligibility criteria for inclusion in this study was
that the individual must be registered with the study
HIV clinics, aged 18 years and above, fluent in English
or Luganda (the local language into which the study
instruments had been translated) and not too physically
and mentally sick (as examined by the attending clini-
cian to undertake the interview). In this component of
the study trained psychiatric nurses recruited from
Uganda’s National Psychiatric Referral hospital at Buta-
bika conducted structured interviews to determine the
prevalence and correlates of psychiatric disorders among
the respondents.
Data collection tools
The data collection tool for the cross sectional study
component consisted of various structured and standar-
dized modules which were translated into Luganda (the
local language spoken in the study area), many of these
modules were developed in the west have not been for-
mally validated in the African context of Uganda. These
tools were administered by trained psychiatric nurses,
these included:
1) Socio-demographic factors sex, age, marital status,
highest educational attainment, religion, and employ-
ment status.
2) Social factors i) ‘food insecurity’(assessed by the
question, ’in the last month, did you or your family have
enough food?’); ii) distance from the HIV clinic; iii) ’dura-
tion of awareness of HIV status’; iv) ’Negative life events
score index’, constructed from items of the adverse life
events module of the European Parasuicide Interview
Schedule that has previously been modified for the
Ugandan situation by Kinyanda and colleagues (2005)
[14,15]. For this study respondents were required to
report whether they had experienced each of these
events in the last 6 months. Items that were selected for
inclusion in this study were those that were thought to
be relevant to the HIV social situation in Uganda. The
negative life events considered in this study looked at
bereavement, severe illness and severe interpersonal
conflict in the following significant social relationships
parent, sibling, spouse/lover and child(ren). The indivi-
dual related negative life events considered in this study
examined for severe sickness, interpersonal conflict, feel-
ings of isolation and abandonment, lack of the basic
requirements of food, shelter and medicine, job loss, dis-
crimination and worries about personal finances. A total
score was generated to reflect the total number of life
events reported, this scale had an a Cronbach of 0.82 in
this study; v) ‘Stress Score index’, constructed by scoring
each of the reported negative life events on a 3 point
Likert scale where respondents were asked the question,
’how stressful did you find the event?’ with possible
responses being: 0 = (not stressing/minimal stressing), 1
= (moderately stressing), 2 = (severely stressing). A total
score was generated where high scores reflected more
stress; vi) ‘Social support index’, constructed from items
of the social support module of the European Parasui-
cide Interview Schedule [14]. This scale has four sub-
scales each with 4 items that assess the following social
support dimensions: ‘need for social support’, ‘receive
the required social support’, ‘felt needed for social sup-
port’ and ‘felt was providing the required social support’.
Each of the items in these sub-scales is scored on a 3
point Likert scale where 1 = (not at all), 2 = (to some
extent), and 3 = (yes, very much). Items of the sub-scale
‘need for social support’ were reverse scored so that
higher scores on this indicated better social support just
like the other three sub-scales. A total score was gener-
ated with higher scores reflecting better social support,
the a Cronbach of this scale in this study was 0.84.
2) Psychological and clinical factors i) Psychiatric dis-
orderwas assessed using the M.I.N.I. neuropsychiatric
interview (MINI Plus) which is a modular DSM IV
based structured interview [16]. The psychiatric disorder
modules used in this study were major depressive disor-
der, suicidality, alcohol use disorders, generalised anxiety
disorder and post-traumatic stress disorder; ii) ‘Negative
coping style index’was constructed from variables of the
Mental Adjustment to Cancer Scale (MAC) whose items
had been adapted to the local HIV situation [17]. Each
of this scale’s 17 questionnaire items is scored on a 4-
item Likert scale 1 = (definitely does not apply to me), 2
= (does not apply to me), 3 = (applies to me), 4 = (defi-
nitely applies to me). To score all the questionnaire
items so that they are all in the same direction i.e.
higher scores reflecting more negative coping style
required that questionnaires items (1,4,5,10,11,12,
13,15,16) that are cast positively such as item 1: ’I have
been doing things that I believe will improve my health
e.g. changed my diet.’ be reverse scored. A total score
was generated so that higher scores reflected a more
negative coping style, the a Cronbach of this scale in
this study was 0.58; iii) ‘past psychiatric history’was
assessed by the question, ’have you ever suffered from
any nervous or psychiatric condition?); iv) ‘family history
of psychiatric disorder’; v) ‘neurocognitive impairment’
assessed using the International HIV Dementia Scale
[18]; vi) ‘Psychosocial impairment index’constructed
from the three variables ’in the last month, on how
many days were your normal activities disrupted through
illness?’ (with responses scored as follows: none = score
0, one and above = score 1); ’how many times did you
visit the health unit in the last month?’ (with responses
scored as follows: none = score 0, one and above =
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score 1), ’for how many days were you admitted to hos-
pital in the last month?’ (with responses scored as fol-
lows: none = score 0, one and above = score 1). A total
score was generated so that higher scores reflected more
impairment, this scale had an a Cronbach of 0.54; vii)
most recent CD4 count; and viii) body mass index.
Statistical analysis
A conceptual framework (Figure 1) based on the stress-
vulnerability model for depression was specified a priori
to guide the multivariate analyses [19].
Statistical analysis was undertaken using both SPSS
(reliability tests) and STATA. Logistic regression models
were used to assess univariate associations between the
dependent variable (major depressive disorder) and
independent variables, grouped in sets of demographic,
social and psychological risk factors, with unadjusted
and adjusted Odds ratio (adjusted for sex and age
group) reported. After adjusting within each set of risk
factors, those that were associated with MDD at a level
of significance of 0.1 were entered into a multivariable
model to determine their independent effect on MDD.
Factors which remained associated with MDD at p <
0.05 were retained in the final model.
Ethical Considerations
The study obtained ethical approval from the Uganda
Virus Research Institute’s Science and Ethics Commit-
tee, the Uganda National Council of Science and Tech-
nology and the London School of Hygiene Ethics
Committee. Study participants were invited to consent
after being provided with adequate information about
the study. Respondents found to have significant psy-
chiatric problems were referred to the psychiatric
department at Entebbe district hospital for further
assessment and management.
Results
Study population
From 6th May 2010 to 10th August 2010, 680 patients
attending the HIV clinics at Entebbe hospital and Kigungu
health centre were screened and given appointments to be
interviewed for this study. Of these 618 (90.9%) were even-
tually enrolled into the study while 62 (4.9%) failed to turn
       Individual    Vulnerability Major 
depressive 
disorder 
       HIV/AIDS 
-Neurotoxic    
effects     Stress 
Adverse life events 
           Socio-
demographic factors      
-female gender                 
-older age                          
-low education                 
- unemployment              
d/ d d
Negative Psychological 
& social factors                     
- negative coping style         
- past psychiatric history 
–comorbid psychiatric  
disorders                             
-poor social support         
Genetic predisposition 
–family history of 
psychiatric illness 
Figure 1 Conceptual framework based on the Stress-Diathesis Model.
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up for their interview appointment even after being
repeatedly contacted by telephone. Those who refused to
participate in this study did not differ significantly from
those who were enrolled into the study on gender and age.
Of those who were enrolled into the study, Entebbe dis-
trict hospital contributed 531 (85.9%) while the smaller
Kigungu Health Centre III contributed 87 (14.1%). The
population served by the two health centres was similar in
terms of gender and age.
Prevalence and socio-demographic risk factors of major
depressive disorder
The prevalence of major depressive disorder in this
study was 8.1% (95% CI, 5.9%- 10.2%).
Table 1 depicts the socio-demographic characteristics,
with 449 (72.7%) females, and 455 (73.7%) patients in
the 25-44 age band. Majority 553 (89.4%) of individuals
had at least seven years of formal education but with
only 53 (8.6%) having gone on to attain a tertiary educa-
tion. 275 (48.5%) were married or currently living with
someone, 75 (13.2%) widowed and 132 (23.3%) sepa-
rated or divorced. Majority 262 (42.4%) were employed
as small scale tradespersons, artisans or in the transport
business (taxi drivers, taxi conductors and boda boda
riders-motorcycle taxis).
On socio-demographic factors (Table 1), only female
gender was associated with MDD in the unadjusted ana-
lysis. After adjusting for age, there was some evidence
that female gender was associated with MDD (adjusted
odds ratio (aOR) = 2.0, p = 0.08). Educational attain-
ment, religion, marital status and occupation were not
significantly associated with MDD.
Social factors associated with major depressive disorder
Table 2 majority 358 (57.9%) lived 6 Km or more from
the HIV clinic they were attending. Sixty nine (11.2%)
respondents reported food insecurity for themselves and
their families. Majority 465 (75.6%) had known their
HIV status for 13 or more months, with most 399
(64.6%) on ART.
After adjusting for age and sex, the social factors sig-
nificantly associated with MDD were (Table 2): food
insecurity (aOR 2.9, P = 0.004); increasing number of
negative life events experienced in the last 6 months, for
Table 1 Socio-demographic correlates of Major Depressive Disorder
Number in study (N,%) Major depressive disorder (n,%) Unadjusted OR
(95% CI)
Adjusted OR§
(95% CI)
Sex P = 0.032 P = 0.077
Male 169 (27.3) 7 (4.1) 1 1
Female 449 (72.7) 43 (9.6) 2.45 (1.08-5.56) 2.04 (0.88-4.75)
Age (years) P = 0.106 P = 0.018
19-24 58 (9.4) 2 (3.4) 1 1
25-34 238 (38.6) 31 (13.0) 4.19 (0.97-18.06) 4.28 (0.99-18.46)
35-44 217 (35.1) 12 (5.5) 1.64 (0.36-7.54) 1.93 (0.42-8.96)
45+ 103 (16.7) 5 (4.9) 1.43 (0.27-7.61) 1.69 (0.31-9.08)
Marital status P = 0.848 P = 0.936
Currently married/cohabiting 275 (48.5) 23 (46.0) 1 1
Widowed 75 (13.2) 8 (16.0) 1.28 (0.55-2.97) 1.30 (0.52-3.24)
Separated/Divorced 132 (23.3) 11 (22.0) 0.99 (0.47-2.11) 0.91 (0.42-1.95)
Single 85 (15.0) 8 (16.0) 1.13 (0.49-2.61) 1.04 (0.44-2.46)
Education level P = 0.839 P = 0.545
No education 65 (10.5) 7 (10.8) 1 1
Primary only 289 (46.8) 19 (6.6) 0.58 (0.23-1.45) 0.61 (0.24-1.55)
Secondary/above 264 (42.7) 24 (10.9) 0.83 (0.34-2.02) 0.98 (0.40-2.43)
Religion P = 0.494 P = 0.250
Christians 535 (86.9) 45 (8.4) 1 1
Moslems 81 (13.1) 5 (6.2) 0.72 (0.30-1.87) 0.57 (0.21-1.49)
Employment Status P = 0.460 P = 0.171
Farmer/Fisherman 97 (15.7) 10 (10.3) 1 1
Professional/clerical 43 (7.0) 2 (4.7) 0.42 (0.09-2.03) 0.37 (0.08-1.83)
Tradesperson/artisan/transport worker 262 (42.4) 21 (8.0) 0.76 (0.34-1.67) 0.53 (0.23-1.22)
Unemployed/house Wife 131 (21.2) 13 (9.9) 0.96 (0.40-2.29) 0.62 (0.24-1.59)
Others (including students) 84 (13.6) 4 (4.8) 0.43 (0.13-1.44) 0.35 (0.10-1.19)
§Adjusted for sex and age
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6-10 events (aOR 4.3), 11+ events (aOR 16.7), P < 0.001
relative to the odds associated with reporting 1-5 events;
and increasing stress scores, those with high stress
scores (aOR 7.2), medium stress scores (aOR 1.7), P <
0.001 relative to the odds associated with low stress
scores. Factors not significantly associated with MDD
were: ‘distance from HIV clinic’, ‘when got to know HIV
status’, ‘being on ART’, and social support. Furthermore,
ORs for the association of stress scores, and of negative
life events, and MDD did not change when adjusted for
social support, indicating that social support did not
moderate the effect of these factors.
Adjusting for negative life events, or increasing stress
scores, greatly attenuated the association of female gen-
der with MDD, indicating that the effect of gender was
mediated through more proximate social factors.
Women reported more negative life events than men
(46% reporting 6+ events in past 6 months vs 36% of
men), and higher stress scores (24% with high stress
scores vs 13% of men).
Psychological and clinical factors correlated with MDD
Table 3 depicts the psychological and clinical factors, 16
(2.6%) had a past psychiatric history, while 120 (19.6%)
had a family history of psychiatric illness. 396 (64.1%)
had significant HIV associated neurocognitive impair-
ment (a score of 10 or less on the International HIV
Dementia Scale; Sacktor et al, 2005). The prevalence of
psychiatric disorders/problems reported included post
traumatic stress disorder 10 (1.6%), generalised anxiety
disorder 5 (0.8%), alcohol dependency disorder 4 (0.7%)
and life-time attempted suicide 24 (3.9%). On CD4
counts, 66 (12.5%) had < 100 cells/μL, 159 (30.2%) had
100-249 cells/μL while 220 (35.6%) had +350 cells/μL,
the majority 387 (64.9%) had a normal BMI.
After adjusting for age and sex, factors significantly asso-
ciated with MDD were: negative coping style index score
(aOR 3.2 for high negative coping index score relative to
low negative coping style index score, P = 0.008); a family
history of psychiatric illness (aOR 2.6, P = 0.003); psycho-
social impairment (aOR 2.7, P = 0.003); and the psychiatric
disorders/problems of post traumatic stress disorder (aOR
43.8, P = < 0.001), generalised anxiety disorder (aOR 61.9,
P = 0.001), alcohol dependency disorder (aOR 24.4, P =
0.003) and life-time attempted suicide (17.5, P < 0.001).
Factors not significantly associated with MDD were
past history of psychiatric illness, HIV associated neuro-
cognitive impairment, CD 4 counts and BMI.
Table 2 Social correlates of Major Depressive Disorder
Number in study (N,%) Major depressive disorder (n,%) Unadjusted OR
(95% CI)
Adjusted OR§
(95% CI)
Food Security P = 0.004 P = 0.004
Enough 549 (88.8) 38 (6.9) 1 1
Not enough 69 (11.2) 12 (17.4) 2.83 (1.40-5.73) 2.89 (1.40-5.98)
Distance from HIV Clinic P = 0.744 P = 0.673
Less than 3 km 94 (15.2) 5 (5.3) 1 1
3 to 5 km 166 (26.9) 17 (10.2) 2.03 (0.72-5.69) 1.87 (0.66-5.30)
More than 5 km 358 (57.9) 28 (7.8) 1.51 (0.57-4.02) 1.51 (0.56-4.07)
When knew HIV Status P = 0.716 P = 0.912
Up to 12 months ago 150 (24.4) 13 (8.7) 1 1
More than 12 months 465 (75.6) 36 (7.7) 1.13 (0.58-2.19) 1.04 (0.52-2.07)
On ART P = 0.482 P = 0.686
Yes 399 (64.6) 30 (7.5) 0.81 (0.45-1.46) 0.88 (0.47-1.64)
No 219 (35.4) 20 (?) 1 1
Social Support P = 0.127 P = 0.236
Low 188 (30.4) 20 (10.6) 1.59 (0.88-2.87) 1.44 (0.79-2.64)
High 430 (69.6) 30 (7.0) 1 1
Negative life events P < 0.001 P < 0.001
1-5 events 350 (56.6) 8 (2.3) 1 1
6-10 events 191 (43.7) 29 (10.7) 4.72 (2.03-11.01) 4.29 (1.83-10.06)
11 + 77 (12.5) 23 (29.9) 18.21 (7.75-42.78) 16.67 (7.01-39.66)
Stress Score index P < 0.001 P < 0.001
Low (score 0) 164 (26.5) 5 (3.0) 1 1
Medium (score 1-10) 323 (52.3) 18 (5.6) 1.88 (0.68-5.15) 1.74 (0.63-4.81)
High (score > 10) 131 (21.2) 27 (20.6) 8.26 (3.08-22.12) 7.18 (2.65-19.47)
§Adjusted for sex and age
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Factors associated with MDD at multivariate analysis
Table 4 in the final multivariable model, increasing
number of negative life events, psychosocial impairment,
life-time attempted suicide, post traumatic stress disor-
der and generalised anxiety disorder were independently
associated with MDD at p < 0.05.
Discussion
The paper sought to investigate the prevalence and the
psychological, social and biological risk factors of major
depressive disorder (MDD) in HIV/AIDS in the African
socio-cultural context. The principal finding of this
study is that among ambulatory HIV/AIDS patients in
the sub-Saharan African environment of Uganda, psy-
chosocial impairment, increasing negative life events and
the co-morbid psychiatric disorders/problems of post
traumatic stress disorder, generalised anxiety disorder
and life-time attempted suicide were the strongest
independent determinants of MDD. Also associated
with an increased risk for MDD in this study were the
following psychological (family history of psychiatric dis-
order, negative coping style, alcohol dependency disor-
der), social (food insecurity, stress, poor social support)
and socio-demographic (female gender) factors. In this
study none of the investigated markers of direct HIV
involvement including of the central nervous system
(neurocognitive impairment, CD4 counts and BMI) were
significantly associated with MDD. These results suggest
while psychological and social factors were important
risk factors for MDD among ambulatory HIV/AIDS per-
sons in this socio-cultural environment, there was no
evidence to support the role of the neurotoxic effects of
HIV in MDD this sub-population of HIV/AIDS patients.
The prevalence of major depressive disorder obtained
in this study was 8.1% a figure comparable to that of
9.6% reported by Chisanga et al (2011) in Zambia, 11.4%
Table 3 Psychological and Clinical correlates of Major Depressive Disorder
Number in study (N,%) Major depressive disorder (n,%) Unadjusted OR
(95% CI)
Adjusted OR§
(95% CI)
Negative Coping Style index P = 0.002 P = 0.008
Low 101 (16.3) 4 (4.0) 1 1
Medium 322 (52.1) 20 (6.2) 1.61 (0.54-4.81) 1.55 (0.51-4.68)
High 195 (31.6) 26 (13.3) 3.73 (1.26-11.01) 3.16 (1.06-9.43)
Past Psychiatric history P = 0.516 P = 0.570
Present 16 (2.6) 2 (12.5) 1.65 (0.36-7.47) 1.56 (0.33-7.28)
Family history of psychiatric illness P = 0.003 P = 0.003
Present 120 (19.6) 18 (15.0) 2.54 (1.37-4.71) 2.57 (1.37-4.83)
Neurocognitive Impairment P = 0.531 P = 0.535
Present 396 (64.1) 30 (7.6) 0.83 (0.0.46-1.50) 0.83 (0.45-1.51)
Psychosocial Impairment P = 0.003 P = 0.003
Present 318 (51.5) 36 (72.0) 2.61 (1.38-4.94) 2.65 (1.39-5.06)
Life-time attempted suicide P < 0.001 P < 0.001
Present 24 (3.9) 13 (26.0) 17.79 (7.46-42.43) 17.51 (6.94-44.11)
Post traumatic Stress disorder P < 0.001 P < 0.001
Present 10 (1.6) 8 (80.0) 53.91 (11.09-261.9) 43.76 (8.62-222.09)
Generalized anxiety disorder P = 0.001 P = 0.001
Present 5 (0.81) 4 (80.0) 49.30 (5.40-450.3) 61.90 (5.90-649.0)
Alcohol dependency disorder P = 0.015 P = 0.003
Present 4 (0.65) 2 (50.0) 11.79 (1.62-85.57) 24.35 (3.00-197.7)
Most Recent CD4 count (cells/μL) P = 0.413 P = 0.555
< 100 66 (12.5) 4 (6.1) 1 1
100-249 159 (30.2) 11 (6.9) 1.15 (0.35-3.76) 1.14 (0.34-3.80)
250-349 81 (15.4) 7 (8.6) 1.47 (0.41-5.24) 1.39 (0.38-5.11)
350+ 220 (35.6) 19 (8.6) 1.46 (0.48-4.47) 1.35 (0.43-4.24)
BMI Index P = 0.550 P = 0.288
Underweight 55 (9.2) 4 (7.3) 1 1
Normal 387 (64.9) 36 (9.3) 1.33 (0.46-3.89) 1.07 (0.36-3.22)
Overweight 119 (20.0) 6 (5.0) 0.70 (0.19-2.60) 0.52 (0.13-1.97)
Obese 35 (5.9) 3 (8.6) 1.22 (0.26-5.80) 0.86 (0.17-4.30)
§Adjusted for sex and age
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reported by Adewuya et al (2007) in Nigeria and 2.7%
reported by Marwick and Kaaya (2010) in rural Tanza-
nia [9,13,20]. All three studies above derived from sub-
Saharan Africa used international diagnostic criteria to
make a diagnosis of MDD just like we did in this study.
However the picture on prevalence of MDD in HIV/
AIDS is more complex than this, other studies underta-
ken both in South Africa and more recently in Uganda
that used international diagnostic criteria reported rates
of MDD as high as 40% [5,21]. This wide variability in
rates of MDD has previously been noted by Judd and
colleagues (1994) in a review of studies on MDD in
HIV/AIDS [22]. Judd and colleagues (1994) attributed
this wide variations in rates of MDD to a number of fac-
tors many of which are still relevant today, these
included: methodological challenges in assessing MDD
in somatically ill patients; differences in the composition
of the study samples on ‘at risk groups’ (commercial sex
workers, injection drug abusers, men who have sex with
men, discordant couples, high risk occupational groups
such as fisherfolk, and persons who acquired HIV peri-
natally) and on the different HIV clinical stages; whether
the study population was predominantly in-patient or
out-patient; and geographical differences [22]. Judd et al.
(1994) summarised their observation by stating that it
was not yet possible to come to a clear conclusion
about the prevalence of MDD in HIV/AIDS, a summary
which still seems to be pertinent to the sub-Saharan
African setting today [22].
In this study female gender conferred a twofold
increased odds for MDD relative to the male gender. A
positive association between female gender and MDD
in HIV/AIDS has previously been reported in Africa by
both Kaharuza et al (2006) in Uganda and Orley et al
(2004) in South Africa [6,12]. Some of the gender dif-
ferences in MDD have been attributed to the more
likelihood of females than males to become victims of
traumatic experiences such as sexual, physical and
emotional abuse both in childhood and in adulthood
[23]. Indeed in this study females reported more nega-
tive life events than males and adjusting for the more
proximal factors of negative life events and increasing
stress scores greatly attenuated the association of
female gender with MDD. Contrary to a common find-
ing in research in this area [24], adjusting for social
support in this study did not reduce the strong asso-
ciation between MDD and negative life events nor the
strong association between MDD and stress scores
indicating that social support did not moderate these
effects in this study.
The significant association between MDD and food
insecurity has previously been described in both low
and high income settings [25,26]. The exact direction of
causality between MDD in HIV/AIDS and food insecur-
ity and the underlying mechanisms are not known and
should be investigated. Possible explanatory mechanisms
include food insecurity (in low income settings) leading
to intense competition for scarce resources and in the
process undermining social solidarity; other studies have
pointed to a possible role for the associated micronutri-
ent deficiency in the aetiology of MDD in HIV/AIDS
[27,28].
In this study a negative coping style was associated
with MDD. In HIV/AIDS, negative coping styles such as
the use of avoidant strategies has been shown to be
associated with MDD [29]. A positive family history of
mental illness was shown to be associated with MDD in
this study. Judd and colleagues (2005) in Australia
observed a positive trend for the influence of a family
history of psychiatric problems and MDD although this
did not attain statistical significance [11]. The observa-
tion in this study of a significant association between
family history of mental illness and MDD suggests a
possible role for genetic predisposition to MDD in this
sub-population of HIV/AIDS patients. Various genetic
polymorphisms including those involving the serotonin
transporter gene have been previously associated with
increased vulnerability to MDD in the general popula-
tion in the context of psychosocial stress [30]. There is
however need to determine the specific mechanisms
underlying genetic vulnerability to MDD among ambu-
latory HIV/AIDS patients in this environment. Psycho-
social impairment was significantly associated with
MDD in this study. In both Orley’s studies in South
Africa, impaired psychosocial function was significantly
associated with MDD [4,11]. In this study just like in
Orley’s studies it was not possible to determine the
direction of causality between impaired psychosocial
function and depression due to the cross-sectional study
design.
Table 4 Final Multivariate Model of risk factors for major
depressive disorder in HIV/AIDS
Odds ratio
(95% CI)
Negative life events P = 0.004
1-5 events 1
6-10 events 3.66 (1.51-8.86)
11 + 8.27 (3.18-21.46)
Psychosocial Impairment P = 0.014
Present 2.41 (1.12-5.15)
Life-time attempted suicide P < 0.001
Present 9.47 (3.36-26.73)
Post traumatic Stress disorder P = 0.003
Present 14.07 (2.46-80.49)
Generalized anxiety disorder P = 0.028
Present 20.01 (1.98-202.2)
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In this study comorbid psychiatric disorders/problems
of PTSD, generalized anxiety disorder, alcohol depen-
dency disorder and life-time attempted suicide were sig-
nificantly associated with MDD. Given the cross
sectional design of this study, it was not possible to
determine the direction of causality between these
comorbid psychiatric disorders and MDD in this study.
However in a prospective study in the US, Atkinson and
colleagues (2008) reported that lifetime multiple psy-
chiatric comobidity was the most potent predictor of
incident MDD episodes among HIV infected men [31].
Neurocognitive impairment in this study, though high,
was not associated with MDD. A similar observation
was made by Atkinson and colleagues (2009) in the U.S.
A. and Judd and colleagues (2005) in Australia [11,31].
None of the markers of HIV disease progression (CD4
counts and BMI) was significantly associated with MDD
in this study. Akena and colleagues (2010) in their study
in Uganda observed no association between MDD and
CD4 counts [32]. Ciesla and Roberts (2001) in a meta-
analysis involving 10 studies concluded that HIV stage
was not a factor in MDD [33].
The findings from this study whereby neurocognitive
impairment and markers of HIV disease progression
were not significantly associated with MDD suggest that
there is a minimal role for the neurotoxic effects of the
HIV virus in the aetiology of MDD in ambulatory HIV
patients in this socio-cultural environment. Judd and
colleagues (2005) in Australia among ‘well’ PLWHA
made a similar observation [11]. However to confirm
this observation will require the study of more specific
and sensitive markers of HIV associated inflammation
such as the pro-inflammatory proteins [10].
There is however evidence from studies both underta-
ken in Uganda and an earlier study undertaken in the
US for a possible neurotoxic role of HIV in the aetiology
of MDD [10,34,35]. Two study groups in Uganda (with
one involving the author, EK) have reported evidence
for HIV associated organic affective disorder syndromes
among HIV positive persons with severe mental illness
[34,35]. Earlier in the US, Lyketsos and colleagues
(1996) in a longitudinal study reported a dramatic sus-
tained rise in depressive symptoms18-24 months before
the onset of clinical AIDS a phenomenon they attribu-
ted to the widespread dysregulation of the immune sys-
tem around this period [10]. These results taken
together suggest a possible neurotoxic role of HIV in
the aetiology of MDD. There is however need for more
research in this area to better understand this
phenomenon.
Conclusions
The results from this study similar to what Judd and
colleagues (2005) have reported in Australia suggest that
the main risk factors for MDD among ambulatory
PLWHA are psychological and social factors with no
evidence for the neurotoxic effects of the HIV virus
[11]. Arising from these results we can recommend that
among ambulatory PLWHA in this socio-cultural envir-
onment, treatment approaches of MDD in HIV/AIDS
should be modeled on those used for treating MDD in
non-HIV groups. There is however need for more stu-
dies to confirm these findings in other sub-Saharan Afri-
can settings.
Limitations of this study include firstly, that the cross
sectional nature of this study made it difficult to deter-
mine the direction of causality of the factors associated
with MDD. Therefore, there is need for longitudinal stu-
dies to establish the exact causal direction between
MDD and many of the investigated variables. Secondly,
a number of the tools used to assess various psychoso-
cial constructs have not been locally validated. These
tools were however locally adapted through a forward
and backward translation process and to minimise bias,
only those tools with a minimum a Cronbach of 0.50
were used in the analysis for this paper.
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